Serum FGF21 levels in adult m.3243A>G carriers: Clinical implications

OBJECTIVES:To determine the value of fibroblast growth factor 21 (FGF21), a recently discovered biomarker for mitochondrial disease, in predicting clinical disease severity and disease progression in adult carriers of the m.3243A>G mutation. METHODS:In the context of a national inventory, the het...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 2014-07, Vol.83 (2), p.125-133
Hauptverfasser:	Koene, Saskia, de Laat, Paul, van Tienoven, Doorlène H, Vriens, Dennis, Brandt, André M, Sweep, Fred C.G.J, Rodenburg, Richard J.T, Donders, A. Rogier T, Janssen, Mirian C.H, Smeitink, Jan A.M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Biomarkers - blood Cohort Studies Disease Progression Female Fibroblast Growth Factors - blood Fibroblast Growth Factors - genetics Follow-Up Studies Heterozygote Humans Injuries of the nervous system and the skull. Diseases due to physical agents Leukocytes - chemistry Male Medical sciences Mitochondrial Diseases - blood Mitochondrial Diseases - genetics Mitochondrial Encephalomyopathies - blood Mitochondrial Encephalomyopathies - genetics Mitochondrial Myopathies - blood Mitochondrial Myopathies - genetics Mutation - genetics Neurology Prognosis Traumas. Diseases due to physical agents
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!